• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病与癌症:一种危险的关联。

Cardiovascular Disease and Cancer: A Dangerous Liaison.

作者信息

Newman Alexandra A C, Dalman Jessie M, Moore Kathryn J

机构信息

Cardiovascular Research Center, New York University Langone Health (A.A.C.N., J.M.D., K.J.M.).

Leon H. Charney Division of Cardiology, Department of Medicine (A.A.C.N., J.M.D., K.J.M.), New York University Grossman School of Medicine.

出版信息

Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):359-371. doi: 10.1161/ATVBAHA.124.319863. Epub 2025 Jan 9.

DOI:10.1161/ATVBAHA.124.319863
PMID:39781742
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11864891/
Abstract

The field of cardio-oncology has traditionally focused on the impact of cancer and its therapies on cardiovascular health. Mounting clinical and preclinical evidence, however, indicates that the reverse may also be true: cardiovascular disease can itself influence tumor growth and metastasis. Numerous epidemiological studies have reported that individuals with prevalent cardiovascular disease have an increased incidence of cancer. In parallel, studies using preclinical mouse models of myocardial infarction, heart failure, and cardiac remodeling support the notion that cardiovascular disorders accelerate the growth of solid tumors and metastases. These findings have ushered in a new and burgeoning field termed reverse cardio-oncology that investigates the impact of cardiovascular disease pathophysiology on cancer emergence and progression. Recent studies have begun to illuminate the mechanisms driving this relationship, including shared risk factors, reprogramming of immune responses, changes in gene expression, and the release of cardiac factors that result in selective advantages for tumor cells or their local milieu, thus exacerbating cancer pathology. Here, we review the evidence supporting the relationship between cardiovascular disease and cancer, the mechanistic pathways enabling this connection, and the implications of these findings for patient care.

摘要

传统上,心脏肿瘤学领域主要关注癌症及其治疗方法对心血管健康的影响。然而,越来越多的临床和临床前证据表明,反之亦然:心血管疾病本身可能影响肿瘤的生长和转移。大量流行病学研究报告称,患有心血管疾病的个体患癌症的几率更高。与此同时,使用心肌梗死、心力衰竭和心脏重塑的临床前小鼠模型进行的研究支持了心血管疾病会加速实体肿瘤生长和转移这一观点。这些发现开创了一个新的、蓬勃发展的领域,即逆向心脏肿瘤学,该领域研究心血管疾病病理生理学对癌症发生和进展的影响。最近的研究已经开始阐明驱动这种关系的机制,包括共同的风险因素、免疫反应的重新编程、基因表达的变化以及心脏因子的释放,这些因素导致肿瘤细胞或其局部环境具有选择性优势,从而加剧癌症病理。在此,我们综述了支持心血管疾病与癌症之间关系的证据、促成这种联系的机制途径以及这些发现对患者护理的意义。

相似文献

1
Cardiovascular Disease and Cancer: A Dangerous Liaison.心血管疾病与癌症:一种危险的关联。
Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):359-371. doi: 10.1161/ATVBAHA.124.319863. Epub 2025 Jan 9.
2
Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease.逆向心血管肿瘤学:心血管疾病患者的癌症发展
J Am Heart Assoc. 2020 Jan 21;9(2):e013754. doi: 10.1161/JAHA.119.013754.
3
[Heart and cancer: cardio-oncology].[心脏与癌症:心血管肿瘤学]
Herz. 2024 Mar;49(2):111-117. doi: 10.1007/s00059-024-05232-7. Epub 2024 Jan 30.
4
Evolving perspectives in reverse cardio-oncology: A review of current status, pathophysiological insights, and future directives.逆向心脏肿瘤学的发展视角:当前状况、病理生理学见解及未来方向综述
Curr Probl Cardiol. 2024 Mar;49(3):102389. doi: 10.1016/j.cpcardiol.2024.102389. Epub 2024 Jan 4.
5
Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology.炎症:癌症、衰老和心血管疾病的共同诱因——拓展心血管肿瘤学概念。
Cardiovasc Res. 2019 Apr 15;115(5):824-829. doi: 10.1093/cvr/cvz058.
6
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.计划接受心脏毒性癌症治疗的癌症患者的基线心血管风险评估:心力衰竭协会欧洲心脏病学会的心脏肿瘤学研究小组与国际心脏肿瘤学会合作的立场声明和新的风险评估工具。
Eur J Heart Fail. 2020 Nov;22(11):1945-1960. doi: 10.1002/ejhf.1920. Epub 2020 Aug 6.
7
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart.癌症患者的心脏功能障碍:超越抗癌药物对心肌细胞的直接损伤:ESC 心肌功能工作组和心脏细胞生物学工作组 2019 年联合会议的心脏肿瘤学新见解。
Cardiovasc Res. 2020 Sep 1;116(11):1820-1834. doi: 10.1093/cvr/cvaa222.
8
Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.精准心脏肿瘤学建模:利用人诱导多能干细胞进行风险分层和预防。
Curr Oncol Rep. 2021 May 3;23(7):77. doi: 10.1007/s11912-021-01066-2.
9
The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population.COVID-19 大流行及其对心血管肿瘤患者人群的影响。
Curr Oncol Rep. 2020 May 28;22(6):60. doi: 10.1007/s11912-020-00945-4.
10
Cardio-oncology for the general physician: 'old' and 'new' cardiovascular toxicities and how to manage them.心血管肿瘤学:普通内科医师须知的“老”和“新”心血管毒性及其处理方法。
Br J Hosp Med (Lond). 2020 Sep 2;81(9):1-11. doi: 10.12968/hmed.2020.0269. Epub 2020 Sep 26.

引用本文的文献

1
Concerns and recommendations: antiplatelet agents and cancer prevention in non-alcoholic fatty liver disease.关注与建议:非酒精性脂肪性肝病中的抗血小板药物与癌症预防
Front Oncol. 2025 Jul 14;15:1607955. doi: 10.3389/fonc.2025.1607955. eCollection 2025.
2
Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation.癌症和心血管疾病的风险因素及预防:先有鸡还是先有蛋的问题。
J Clin Med. 2025 Apr 29;14(9):3083. doi: 10.3390/jcm14093083.

本文引用的文献

1
Why do patients with cancer die?为什么癌症患者会死亡?
Nat Rev Cancer. 2024 Aug;24(8):578-589. doi: 10.1038/s41568-024-00708-4. Epub 2024 Jun 19.
2
Cancer as an Individual Risk Factor for Heart Failure: A Review of Literature.癌症作为心力衰竭的个体风险因素:文献综述
Cureus. 2024 May 19;16(5):e60592. doi: 10.7759/cureus.60592. eCollection 2024 May.
3
Cancer Incidence Trends in Successive Social Generations in the US.美国连续几代人的癌症发病率趋势。
JAMA Netw Open. 2024 Jun 3;7(6):e2415731. doi: 10.1001/jamanetworkopen.2024.15731.
4
Cancer Incidence After Diagnosis of Abdominal Aortic Aneurysm-Brief Report.腹部主动脉瘤诊断后的癌症发病率——简要报告。
Arterioscler Thromb Vasc Biol. 2024 Jul;44(7):1694-1701. doi: 10.1161/ATVBAHA.123.320543. Epub 2024 May 23.
5
Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: Family Series.细胞衰老作为心血管疾病的一个可靶向风险因素:治疗意义:家族系列研究
JACC Basic Transl Sci. 2024 Apr 8;9(4):522-534. doi: 10.1016/j.jacbts.2023.12.003. eCollection 2024 Apr.
6
Cardiovascular disease and cancer: shared risk factors and mechanisms.心血管疾病和癌症:共同的风险因素和机制。
Nat Rev Cardiol. 2024 Sep;21(9):617-631. doi: 10.1038/s41569-024-01017-x. Epub 2024 Apr 10.
7
Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway.心肌梗死后心力衰竭通过NGF-TRKA途径促进乳腺肿瘤生长。
JACC CardioOncol. 2023 Nov 6;6(1):55-66. doi: 10.1016/j.jaccao.2023.10.002. eCollection 2024 Feb.
8
Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.来自梗死和衰竭心脏的小细胞外囊泡加速肿瘤生长。
Circulation. 2024 May 28;149(22):1729-1748. doi: 10.1161/CIRCULATIONAHA.123.066911. Epub 2024 Mar 15.
9
Why are so many young people getting cancer? What the data say.为什么这么多年轻人患癌症?数据说明了什么。
Nature. 2024 Mar;627(8003):258-260. doi: 10.1038/d41586-024-00720-6.
10
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial.卡那单抗联合多西他赛对比多西他赛单药治疗铂类双药化疗和免疫治疗后进展期非小细胞肺癌(CANOPY-2):一项多中心、随机、双盲、III 期临床试验。
Lung Cancer. 2024 Mar;189:107451. doi: 10.1016/j.lungcan.2023.107451. Epub 2024 Jan 16.